BRCA1 mutation	Solid Tumor	BRCA1 mutation	Solid Tumor	ART558 Sensitive: D – Preclinical ART558 Sensitive : D	ART558 Sensitive: D – Preclinical ART558 Sensitive : D
BRCA2 mutation	Solid Tumor	BRCA2 mutation	Solid Tumor	ART558 Sensitive: D – Preclinical ART558 Sensitive : D	ART558 Sensitive: D – Preclinical ART558 Sensitive : D
TP53 mutation	Solid Tumor	TP53 mutation	Solid Tumor	M3814 + VP-006 Sensitive: D – Preclinical M3814 + VP-006 Sensitive : D	M3814 + VP-006 Sensitive: D – Preclinical M3814 + VP-006 Sensitive : D
ATM deletion	Mantle Cell Lymphoma	ATM deletion	Mantle Cell Lymphoma	VP-006 Sensitive: D – Preclinical VP-006 Sensitive : D	VP-006 Sensitive: D – Preclinical VP-006 Sensitive : D
ATM deletion	Mantle Cell Lymphoma	ATM deletion	Mantle Cell Lymphoma	ART558 Sensitive: D – Preclinical ART558 Sensitive : D	ART558 Sensitive: D – Preclinical ART558 Sensitive : D

POLQ inhibitor

Associations(5)